CONGRESS FOR VOTERS

RepublicanBill · H.R. 1492· House(119-HR-1492)

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Rep. Murphy
Age: 63 years
North Carolina
Introduced
2/21/2025
Last activity
2/21/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by
Gregory Murphy
Cosponsors
Republican - 64Democrat - 4
Health
  1. Introduced
  2. In Committee

What this bill would do

This bill proposes an amendment to title XI of the Social Security Act. The main goal is to equalize the negotiation period between small-molecule and biologic candidates within the Drug Price Negotiation Program. Specifically, it seeks to change a duration from 7 years to 11 years. This change would apply to the negotiation period for certain drug candidates.

Yes

No question was scored yes.

The opposite· 3 of 6

  • Does this lower the price of prescription medicines?-3

    Extending the period before negotiation could delay the reduction of drug prices for small-molecule drugs.

  • Would people over 65 be better off under this?-2

    Delaying drug price negotiations may negatively impact seniors relying on Medicare drug coverage.

  • Would households on low incomes be better off under this?-2

    Extended drug exclusivity could result in higher out-of-pocket costs for low-income families.